title: Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
authors.affiliation: Fred Hutchinson Cancer Research Center, Seattle, WA 98104.
authors.forename: C D
authors.initials: CD
authors.lastname: Buckner
authors.forename: R A
authors.initials: RA
authors.lastname: Clift
authors.forename: F R
authors.initials: FR
authors.lastname: Appelbaum
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: F B
authors.initials: FB
authors.lastname: Petersen
authors.forename: J E
authors.initials: JE
authors.lastname: Sanders
authors.forename: E D
authors.initials: ED
authors.lastname: Thomas
authors.forename: J A
authors.initials: JA
authors.lastname: Hansen
mesh_terms: D016026:Bone Marrow Transplantation / Q000379:methods*; D003520:Cyclophosphamide / Q000008:administration & dosage; D003524:Cyclosporins / Q000008:administration & dosage; D006086:Graft vs Host Disease / Q000401:mortality / Q000517:prevention & control; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000401:mortality / Q000601:surgery*; D015470:Leukemia, Myeloid, Acute / Q000401:mortality / Q000601:surgery*; D015993:Life Tables; D008727:Methotrexate / Q000008:administration & dosage; D011879:Radiotherapy Dosage; D016019:Survival Analysis; D014184:Transplantation, Homologous; D014861:Washington / Q000453:epidemiology; D014916:Whole-Body Irradiation
chemical_list: D003524:Cyclosporins; D003520:Cyclophosphamide; D008727:Methotrexate